Trial Profile
Duloxetine for perimenopausal depression
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2012
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Depressive disorders; Menopausal syndrome
- Focus Therapeutic Use
- 07 Jul 2012 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.
- 07 Jul 2012 Actual patient number is 7 according to ClinicalTrials.gov.
- 07 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.